1138 related articles for article (PubMed ID: 28425490)
21. Implications of gut microbiota dysbiosis and metabolic changes in prion disease.
Yang D; Zhao D; Shah SZA; Wu W; Lai M; Zhang X; Li J; Guan Z; Zhao H; Li W; Gao H; Zhou X; Yang L
Neurobiol Dis; 2020 Feb; 135():104704. PubMed ID: 31837420
[TBL] [Abstract][Full Text] [Related]
22. N-Acetylcysteine alleviates gut dysbiosis and glucose metabolic disorder in high-fat diet-fed mice.
Zheng J; Yuan X; Zhang C; Jia P; Jiao S; Zhao X; Yin H; Du Y; Liu H
J Diabetes; 2019 Jan; 11(1):32-45. PubMed ID: 29845722
[TBL] [Abstract][Full Text] [Related]
23. An integrated fecal microbiome and metabolome in rats reveal variations in gut microbiota and fecal metabolic phenotype of Semen Euphorbiae and Semen Euphorbiae Pulveratum.
Wei X; Wang M; Shi S; Jiang M; Wang Z; Zhang J; Yue Z; Wang H; Chen M; Wang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1211():123459. PubMed ID: 36209673
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota composition modifies fecal metabolic profiles in mice.
Zhao Y; Wu J; Li JV; Zhou NY; Tang H; Wang Y
J Proteome Res; 2013 Jun; 12(6):2987-99. PubMed ID: 23631562
[TBL] [Abstract][Full Text] [Related]
25. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic-induced gut microbiota dysbiosis altered host metabolism.
He M; Shi J; Liu A; Xu YJ; Liu Y
Mol Omics; 2023 May; 19(4):330-339. PubMed ID: 36852671
[TBL] [Abstract][Full Text] [Related]
27. From the Cover: Exposure to Oral Antibiotics Induces Gut Microbiota Dysbiosis Associated with Lipid Metabolism Dysfunction and Low-Grade Inflammation in Mice.
Jin Y; Wu Y; Zeng Z; Jin C; Wu S; Wang Y; Fu Z
Toxicol Sci; 2016 Nov; 154(1):140-152. PubMed ID: 27503388
[TBL] [Abstract][Full Text] [Related]
28. Intervening Effects of Total Alkaloids of
Liu X; Zheng H; Lu R; Huang H; Zhu H; Yin C; Mo Y; Wu J; Liu X; Deng M; Li D; Cheng B; Wu F; Liang Y; Guo H; Song H; Su Z
Front Microbiol; 2019; 10():1151. PubMed ID: 31214133
[TBL] [Abstract][Full Text] [Related]
29. Determining the protective effects of Yin-Chen-Hao Tang against acute liver injury induced by carbon tetrachloride using 16S rRNA gene sequencing and LC/MS-based metabolomics.
Liu F; Sun Z; Hu P; Tian Q; Xu Z; Li Z; Tian X; Chen M; Huang C
J Pharm Biomed Anal; 2019 Sep; 174():567-577. PubMed ID: 31261038
[TBL] [Abstract][Full Text] [Related]
30. Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment.
Kappel BA; De Angelis L; Heiser M; Ballanti M; Stoehr R; Goettsch C; Mavilio M; Artati A; Paoluzi OA; Adamski J; Mingrone G; Staels B; Burcelin R; Monteleone G; Menghini R; Marx N; Federici M
Mol Metab; 2020 Jun; 36():100976. PubMed ID: 32251665
[TBL] [Abstract][Full Text] [Related]
31. Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.
Behr C; Slopianka M; Haake V; Strauss V; Sperber S; Kamp H; Walk T; Beekmann K; Rietjens IMCM; van Ravenzwaay B
Toxicol Appl Pharmacol; 2019 Jan; 363():79-87. PubMed ID: 30502395
[TBL] [Abstract][Full Text] [Related]
32. An integrated fecal microbiome and metabolome in the aged mice reveal anti-aging effects from the intestines and biochemical mechanism of FuFang zhenshu TiaoZhi(FTZ).
Shenghua P; Ziqin Z; Shuyu T; Huixia Z; Xianglu R; Jiao G
Biomed Pharmacother; 2020 Jan; 121():109421. PubMed ID: 31743877
[TBL] [Abstract][Full Text] [Related]
33. Multi-omics reveals the mechanisms of antidepressant-like effects of the low polarity fraction of Bupleuri Radix.
Feng Y; Gao X; Meng M; Xue H; Qin X
J Ethnopharmacol; 2020 Jun; 256():112806. PubMed ID: 32234596
[TBL] [Abstract][Full Text] [Related]
34. NMR-based metabonomic approach reveals changes in the urinary and fecal metabolome caused by resveratrol.
Torres Santiago G; Serrano Contreras JI; Meléndez Camargo ME; Zepeda Vallejo LG
J Pharm Biomed Anal; 2019 Jan; 162():234-241. PubMed ID: 30268024
[TBL] [Abstract][Full Text] [Related]
35. Toxicity, gut microbiota and metabolome effects after copper exposure during early life in SD rats.
Dai J; Yang X; Yuan Y; Jia Y; Liu G; Lin N; Xiao H; Zhang L; Chen J
Toxicology; 2020 Mar; 433-434():152395. PubMed ID: 32027963
[TBL] [Abstract][Full Text] [Related]
36. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the adverse impacts of aflatoxin B
Zhou J; Tang L; Wang JS
Chemosphere; 2019 Feb; 217():618-628. PubMed ID: 30447610
[TBL] [Abstract][Full Text] [Related]
38. Impact of lincosamides antibiotics on the composition of the rat gut microbiota and the metabolite profile of plasma and feces.
Behr C; Ramírez-Hincapié S; Cameron HJ; Strauss V; Walk T; Herold M; Beekmann K; Rietjens IMCM; van Ravenzwaay B
Toxicol Lett; 2018 Oct; 296():139-151. PubMed ID: 30102961
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Oral Vancomycin-Induced Alterations in Gut Bacterial Microbiota and Metabolome of Healthy Men.
Kim AH; Lee Y; Kim E; Ji SC; Chung JY; Cho JY
Front Cell Infect Microbiol; 2021; 11():629438. PubMed ID: 34123865
[TBL] [Abstract][Full Text] [Related]
40. Exposure to a mixture of cigarette smoke carcinogens disturbs gut microbiota and influences metabolic homeostasis in A/J mice.
Qu Z; Zhang L; Hou R; Ma X; Yu J; Zhang W; Zhuang C
Chem Biol Interact; 2021 Aug; 344():109496. PubMed ID: 33939976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
